257 related articles for article (PubMed ID: 16166190)
1. Systematic review of randomized controlled trials of atypical antipsychotics and selective serotonin reuptake inhibitors for behavioural problems associated with pervasive developmental disorders.
Dinca O; Paul M; Spencer NJ
J Psychopharmacol; 2005 Sep; 19(5):521-32. PubMed ID: 16166190
[TBL] [Abstract][Full Text] [Related]
2. Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD).
Williams K; Brignell A; Randall M; Silove N; Hazell P
Cochrane Database Syst Rev; 2013 Aug; (8):CD004677. PubMed ID: 23959778
[TBL] [Abstract][Full Text] [Related]
3. Fluorine magnetic resonance spectroscopy measurement of brain fluvoxamine and fluoxetine in pediatric patients treated for pervasive developmental disorders.
Strauss WL; Unis AS; Cowan C; Dawson G; Dager SR
Am J Psychiatry; 2002 May; 159(5):755-60. PubMed ID: 11986128
[TBL] [Abstract][Full Text] [Related]
4. The pharmacotherapy of target symptoms associated with autistic disorder and other pervasive developmental disorders.
Posey DJ; McDougle CJ
Harv Rev Psychiatry; 2000; 8(2):45-63. PubMed ID: 10902094
[TBL] [Abstract][Full Text] [Related]
5. Pharmacotherapy of pervasive developmental disorders in children and adolescents.
Masi G
CNS Drugs; 2004; 18(14):1031-52. PubMed ID: 15584771
[TBL] [Abstract][Full Text] [Related]
6. Selective serotonin reuptake inhibitors in autism: a review of efficacy and tolerability.
Kolevzon A; Mathewson KA; Hollander E
J Clin Psychiatry; 2006 Mar; 67(3):407-14. PubMed ID: 16649827
[TBL] [Abstract][Full Text] [Related]
7. Atypical antipsychotics for disruptive behaviour disorders in children and youths.
Loy JH; Merry SN; Hetrick SE; Stasiak K
Cochrane Database Syst Rev; 2012 Sep; (9):CD008559. PubMed ID: 22972123
[TBL] [Abstract][Full Text] [Related]
8. The use of selective serotonin reuptake inhibitors in autism and related disorders.
Posey DJ; Erickson CA; Stigler KA; McDougle CJ
J Child Adolesc Psychopharmacol; 2006; 16(1-2):181-6. PubMed ID: 16553538
[TBL] [Abstract][Full Text] [Related]
9. 'Use of selective serotonin reuptake inhibitors in children with pervasive developmental disorder: risk of treatment emergent mania'.
Bates G; Willson SW
Dev Med Child Neurol; 2003 May; 45(5):359; author reply 360. PubMed ID: 12729153
[No Abstract] [Full Text] [Related]
10. Atypical antipsychotics in the treatment of children and adolescents with pervasive developmental disorders.
Politte LC; McDougle CJ
Psychopharmacology (Berl); 2014 Mar; 231(6):1023-36. PubMed ID: 23552907
[TBL] [Abstract][Full Text] [Related]
11. Pharmacotherapy in children and adolescents with pervasive developmental disorders.
Scahill L; Koenig K
J Child Adolesc Psychiatr Nurs; 1999; 12(1):41-3. PubMed ID: 10347430
[TBL] [Abstract][Full Text] [Related]
12. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension-type headache in adults.
Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
Cochrane Database Syst Rev; 2015 May; 2015(5):CD011681. PubMed ID: 25931277
[TBL] [Abstract][Full Text] [Related]
13. Atypical antipsychotics in children with pervasive developmental disorders.
Chavez B; Chavez-Brown M; Sopko MA; Rey JA
Paediatr Drugs; 2007; 9(4):249-66. PubMed ID: 17705564
[TBL] [Abstract][Full Text] [Related]
14. Management of psychiatric disorders in children and adolescents with atypical antipsychotics: a systematic review of published clinical trials.
Jensen PS; Buitelaar J; Pandina GJ; Binder C; Haas M
Eur Child Adolesc Psychiatry; 2007 Mar; 16(2):104-20. PubMed ID: 17075688
[TBL] [Abstract][Full Text] [Related]
15. [Treatment-resistant anxiety disorders: A literature review of drug therapy strategies].
Ammar G; Naja WJ; Pelissolo A
Encephale; 2015 Jun; 41(3):260-5. PubMed ID: 25439852
[TBL] [Abstract][Full Text] [Related]
16. An open pilot study combining risperidone and a selective serotonin reuptake inhibitor as initial antidepressant therapy.
Hirose S; Ashby CR
J Clin Psychiatry; 2002 Aug; 63(8):733-6. PubMed ID: 12197455
[TBL] [Abstract][Full Text] [Related]
17. Selective serotonin-reuptake inhibitors in the treatment of panic disorder: a systematic review of placebo-controlled studies.
Mochcovitch MD; Nardi AE
Expert Rev Neurother; 2010 Aug; 10(8):1285-93. PubMed ID: 20662754
[TBL] [Abstract][Full Text] [Related]
18. Fluvoxamine treatment of a child with severe PDD: a single case study.
Kauffmann C; Vance H; Pumariega AJ; Miller B
Psychiatry; 2001; 64(3):268-77. PubMed ID: 11708052
[TBL] [Abstract][Full Text] [Related]
19. Psychopharmacology of autistic spectrum disorders in children and adolescents.
Nazeer A
Pediatr Clin North Am; 2011 Feb; 58(1):85-97, x. PubMed ID: 21281850
[TBL] [Abstract][Full Text] [Related]
20. [The mental disorder and obsessive-compulsive spectrum disorders in childhood ].
Okada T
Seishin Shinkeigaku Zasshi; 2011; 113(10):992-8. PubMed ID: 22292193
[No Abstract] [Full Text] [Related]
[Next] [New Search]